Mason Lai
Overview
Explore the profile of Mason Lai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai M, Fenton C, Rubin J, Huang C, Pletcher M, Lai J, et al.
medRxiv
. 2024 Nov;
PMID: 39606343
Background And Aims: Hepatorenal syndrome - Acute Kidney Injury (HRS-AKI) is a severe complication of decompensated cirrhosis that is challenging to predict. Sentiment analysis, a computational process of identifying and...
2.
Lai M, Lai J, Allegretti A, Patidar K, Cullaro G
Kidney360
. 2024 Sep;
5(12):1844-1852.
PMID: 39235870
No abstract available.
3.
Sheshadri A, Lai M, Hsu F, Bauer S, Chen S, Tse W, et al.
Kidney Med
. 2023 Nov;
5(11):100721.
PMID: 37915963
Rationale & Objective: In the Lifestyle Interventions and Independence for Elders (LIFE) trial, a structured exercise intervention slowed kidney function decline in sedentary older adults. Biomarkers of kidney health could...
4.
Lai M, Madden E, Shlipak M, Scherzer R, Post W, Vittinghoff E, et al.
AIDS
. 2023 Oct;
38(4):465-475.
PMID: 37861689
Objective: The aim of this study was to determine whether urine biomarkers of kidney health are associated with subclinical cardiovascular disease among men with and without HIV. Design: A cross-sectional...
5.
Lai M, Fenton C, Ge J, Rubin J, Lai J, Cullaro G
Hepatol Commun
. 2023 Sep;
7(10).
PMID: 37756037
Background And Aims: Nonselective beta-blockers (NSBB) protect patients with compensated cirrhosis; however, it is unclear if NSBB is associated with acute kidney injury (AKI) in patients with decompensated cirrhosis. We...
6.
Lai M, Scherzer R, Shlipak M, Madden E, Vittinghoff E, Tse W, et al.
AIDS
. 2023 Aug;
37(15):2339-2348.
PMID: 37650762
Background: People with HIV (PWH) generally have worse ambulatory levels of kidney injury biomarkers and excess risk of acute kidney injury (AKI) compared to persons without HIV. We evaluated whether...
7.
Abbs E, Schoenfeld N, Lai M, Satterwhite S, Zhou S, Bamberger J, et al.
J Urban Health
. 2023 Jan;
100(2):303-313.
PMID: 36652157
In this study, we consider the patient, provider, and public health repercussions of San Francisco's (SF) COVID-related response to homelessness using tourist hotels to house people experiencing homelessness (PEH). We...
8.
Lai M, Aras M, Park M
Clin Transplant
. 2022 Dec;
37(2):e14881.
PMID: 36504467
Background: Despite improved life expectancy from a heart transplant, transplant recipients remain at high risk for renal dysfunction and failure, including end-stage kidney disease (ESKD). The onset of ESKD is...
9.
Lai M, Cheung C, Olgin J, Pletcher M, Vittinghoff E, Lin F, et al.
Am J Cardiol
. 2022 Dec;
187:18-25.
PMID: 36459743
The VEST (Vest Prevention of Early Sudden Death Trial) showed a trend toward decreased sudden death and lower overall mortality with a wearable cardioverter-defibrillator (WCD) in the postmyocardial infarction (post-MI)...
10.
Lai M, Gao Y, Tavakol M, Freise C, Lee B, Park M
Kidney360
. 2022 Jul;
3(6):1080-1088.
PMID: 35845334
Background: The optimal timing of dialysis access placement in individuals with stage 5 CKD is challenging to estimate. Preemptive living donor kidney transplant (LDKT) is the gold-standard treatment for ESKD...